The hypothalamus-pituitary-thyroid axis in critical illness.
暂无分享,去创建一个
[1] G. Van den Berghe,et al. Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness , 2009, Critical care.
[2] I. Rebeyka,et al. Hypothalamic-pituitary-thyroid axis changes in children after cardiac surgery. , 2009, The Journal of clinical endocrinology and metabolism.
[3] G. Van den Berghe,et al. Expression of thyroid hormone transporters during critical illness. , 2009, European journal of endocrinology.
[4] G. Van den Berghe,et al. The type II iodothyronine deiodinase is up-regulated in skeletal muscle during prolonged critical illness. , 2007, The Journal of clinical endocrinology and metabolism.
[5] V. Darras,et al. Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. , 2007, The Journal of clinical investigation.
[6] G. Van den Berghe,et al. Thyroid hormone receptor isoform expression in livers of critically ill patients. , 2007, Thyroid : official journal of the American Thyroid Association.
[7] E. Fliers,et al. Chronic local inflammation in mice results in decreased TRH and type 3 deiodinase mRNA expression in the hypothalamic paraventricular nucleus independently of diminished food intake. , 2006, The Journal of endocrinology.
[8] K. Millen,et al. Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. , 2006, Endocrinology.
[9] C. Fekete,et al. Role of melanocortin signaling in the regulation of the hypothalamic–pituitary–thyroid (HPT) axis , 2006, Peptides.
[10] A. Bianco,et al. Characterization of the nuclear factor-kappa B responsiveness of the human dio2 gene. , 2006, Endocrinology.
[11] G. Van den Berghe,et al. Tissue thyroid hormone levels in critical illness. , 2005, The Journal of clinical endocrinology and metabolism.
[12] G. Van den Berghe,et al. Tissue deiodinase activity during prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone-releasing peptide-2. , 2005, Endocrinology.
[13] G. Van den Berghe,et al. Increased thyroxine sulfate levels in critically ill patients as a result of a decreased hepatic type I deiodinase activity. , 2005, The Journal of clinical endocrinology and metabolism.
[14] W. Hop,et al. Euthyroid sick syndrome in meningococcal sepsis: the impact of peripheral thyroid hormone metabolism and binding proteins. , 2005, The Journal of clinical endocrinology and metabolism.
[15] A. Bianco,et al. Bacterial lipopolysaccharide (LPS)-induced type 2 iodothyronine deiodinase (D2) activation in the mediobasal hypothalamus (MBH) is independent of the LPS-induced fall in serum thyroid hormone levels , 2005, Brain Research.
[16] P. Larsen,et al. Cellular and structural biology of the deiodinases. , 2005, Thyroid : official journal of the American Thyroid Association.
[17] W. Rand,et al. Ascending brainstem pathways are not involved in lipopolysaccharide-induced suppression of thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus. , 2005, Endocrinology.
[18] C. Bailey. Is There Still a Place for Dopamine in the Modern Intensive Care Unit , 2004 .
[19] W. Wiersinga,et al. Interleukin-18, a proinflammatory cytokine, contributes to the pathogenesis of non-thyroidal illness mainly via the central part of the hypothalamus-pituitary-thyroid axis. , 2004, European journal of endocrinology.
[20] E. Fliers,et al. Simultaneous changes in central and peripheral components of the hypothalamus-pituitary-thyroid axis in lipopolysaccharide-induced acute illness in mice. , 2004, The Journal of endocrinology.
[21] W. Rand,et al. Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome. , 2004, Endocrinology.
[22] G. Van den Berghe,et al. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. , 2003, The Journal of clinical endocrinology and metabolism.
[23] P. Larsen,et al. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. , 2002, Endocrine reviews.
[24] G. Van den Berghe. Dynamic neuroendocrine responses to critical illness. , 2002, Frontiers in neuroendocrinology.
[25] E. Fliers,et al. The hypothalamic-pituitary-thyroid axis in critical illness. , 2001, Best practice & research. Clinical endocrinology & metabolism.
[26] V. Kyriazopoulou,et al. Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery. , 2001, The Journal of clinical endocrinology and metabolism.
[27] T. Visser,et al. Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. , 2001, Endocrine reviews.
[28] P. Yen,et al. Physiological and molecular basis of thyroid hormone action. , 2001, Physiological reviews.
[29] T. Hökfelt,et al. Effect of LPS administration on the expression of POMC, NPY, galanin, CART and MCH mRNAs in the rat hypothalamus. , 2001, Brain research. Molecular brain research.
[30] J. Köhrle,et al. Effects of proinflammatory cytokines on anterior pituitary 5'-deiodinase type I and type II. , 2000, The Journal of endocrinology.
[31] M. Bettendorf,et al. Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study , 2000, The Lancet.
[32] A. Butte,et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. , 2000, The New England journal of medicine.
[33] M. Yap,et al. Concordant decreases of thyroxine and thyroxine binding protein concentrations during sepsis. , 2000, Metabolism: clinical and experimental.
[34] M. Yap,et al. Selective consumption of thyroxine-binding globulin during cardiac bypass surgery. , 2000, Metabolism: clinical and experimental.
[35] John P. Johnson,et al. A trial of thyroxine in acute renal failure. , 2000, Kidney international.
[36] D. Zimmerman. Fetal and neonatal hyperthyroidism. , 1999, Thyroid : official journal of the American Thyroid Association.
[37] G. Van den Berghe,et al. Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. , 1998, The Journal of clinical endocrinology and metabolism.
[38] G. Van den Berghe,et al. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. , 1998, The Journal of clinical endocrinology and metabolism.
[39] E. Krenning,et al. The significance of plasma membrane transport in the bioavailability of thyroid hormone. , 1998, Clinical endocrinology.
[40] E. Fliers,et al. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. , 1997, The Journal of clinical endocrinology and metabolism.
[41] G. Van den Berghe,et al. Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone‐secretagogues , 1997, Clinical endocrinology.
[42] G. Naulaers,et al. L-Thyroxine Treatment of Preterm Newborns: Clinical and Endocrine Effects , 1997, Pediatric Research.
[43] W. Wiersinga,et al. Immunoneutralization of interleukin-1, tumor necrosis factor, interleukin-6 or interferon does not prevent the LPS-induced sick euthyroid syndrome in mice. , 1997, The Journal of endocrinology.
[44] G. Van den Berghe,et al. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. , 1997, The Journal of clinical endocrinology and metabolism.
[45] F. Dekker,et al. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. , 1997, The New England journal of medicine.
[46] J. Flier,et al. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. , 1997, Endocrinology.
[47] G. Van den Berghe,et al. Pituitary responsiveness to GH‐releasing hormone, GH‐releasing peptide‐2 and thyrotrophin‐releasing hormone in critical illness , 1996, Clinical endocrinology.
[48] C. Mantzoros,et al. Role of leptin in the neuroendocrine response to fasting , 1996, Nature.
[49] W. Wiersinga,et al. Relationship between serum 3,5,3′-triiodothyronine and serum interleukin-8, interleukin-10 or interferonγ in patients with nonthyroidal illness , 1996, Journal of endocrinological investigation.
[50] G. Van den Berghe,et al. Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations. , 1996, Critical care medicine.
[51] P. Essén,et al. A descriptive study of skeletal muscle metabolism in critically ill patients: free amino acids, energy-rich phosphates, protein, nucleic acids, fat, water, and electrolytes. , 1996, Critical care medicine.
[52] M. Sabljar-Matovinović,et al. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. , 1996, Endocrine reviews.
[53] S. Thomas,et al. Thyroid hormone treatment after coronary-artery bypass surgery. , 1995, The New England journal of medicine.
[54] N. Szeverenyi,et al. Effects of fasting, intermittent feeding, or continuous parenteral nutrition on rat liver and brain energy metabolism as assessed by 31P-NMR , 1995, Physiology & Behavior.
[55] W. Wiersinga,et al. The role of cytokines in the lipopolysaccharide-induced sick euthyroid syndrome in mice. , 1995, The Journal of endocrinology.
[56] B. Bernard,et al. Impaired thyroxine and 3,5,3'-triiodothyronine handling by rat hepatocytes in the presence of serum of patients with nonthyroidal illness. , 1995, The Journal of clinical endocrinology and metabolism.
[57] T. van der Poll,et al. Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man. , 1995, The Journal of clinical endocrinology and metabolism.
[58] H. van Toor,et al. T4 uptake into the perfused rat liver and liver T4 uptake in humans are inhibited by fructose. , 1994, The American journal of physiology.
[59] B. Bernard,et al. Transport of thyroxine into cultured hepatocytes: effects of mild non‐thyroidal illness and calorie restriction in obese subjects , 1994, Clinical endocrinology.
[60] M. Kaplan,et al. Reduced tissue thyroid hormone levels in fatal illness. , 1993, Metabolism: clinical and experimental.
[61] H. van Toor,et al. Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids. , 1993, The Journal of clinical endocrinology and metabolism.
[62] F. Santini,et al. A radioimmunoassay for measurement of 3,5,3'-triiodothyronine sulfate: studies in thyroidal and nonthyroidal diseases, pregnancy, and neonatal life. , 1992, The Journal of clinical endocrinology and metabolism.
[63] T. van der Poll,et al. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. , 1990, The Journal of clinical endocrinology and metabolism.
[64] J. Harney,et al. Thyroid hormone aporeceptor represses T3-inducible promoters and blocks activity of the retinoic acid receptor. , 1989, The New biologist.
[65] T. Visser,et al. Serum triiodothyronine sulfate in man measured by radioimmunoassay. , 1989, The Journal of clinical endocrinology and metabolism.
[66] P. Larsen,et al. Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing , 1989, Nature.
[67] M. Surks,et al. Normal free thyroxine in critical nonthyroidal illnesses measured by ultrafiltration of undiluted serum and equilibrium dialysis. , 1988, The Journal of clinical endocrinology and metabolism.
[68] A. Beddoe,et al. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. , 1987, The Journal of trauma.
[69] R. Evans,et al. The c-erb-A gene encodes a thyroid hormone receptor , 1986, Nature.
[70] H. Beug,et al. The c-erb-A protein is a high-affinity receptor for thyroid hormone , 1986, Nature.
[71] T. Visser,et al. Carrier-mediated transport of thyroid hormone into rat hepatocytes is rate-limiting in total cellular uptake and metabolism. , 1986, Endocrinology.
[72] G. Brent,et al. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. , 1986, The Journal of clinical endocrinology and metabolism.
[73] P. Hamblin,et al. Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. , 1986, The Journal of clinical endocrinology and metabolism.
[74] S. Refetoff,et al. Measurement of thyroxine uptake from serum by cultured human hepatocytes as an index of thyroid status: reduced thyroxine uptake from serum of patients with nonthyroidal illness. , 1985, The Journal of clinical endocrinology and metabolism.
[75] J. Mead,et al. Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3'-triiodothyronine in sera of patients with nonthyroidal illnesses. , 1985, The Journal of clinical endocrinology and metabolism.
[76] D. Jump,et al. Distribution and metabolism of L- and D-triiodothyronine (T3) in the rat: preferential accumulation of L-T3 by hepatic and cardiac nuclei as a probable explanation of the differential biological potency of T3 enantiomers. , 1983, Endocrinology.
[77] A. Mason,et al. Hypermetabolic low triiodothyronine syndrome of burn injury , 1982, Critical care medicine.
[78] V. Bacci,et al. The relationship between serum triiodothyronine and thyrotropin during systemic illness. , 1982, The Journal of clinical endocrinology and metabolism.
[79] T. Visser,et al. Decreased transport of thyroxine (T4), 3,3′‐5‐triiodothyronine (T3) and 3,3′,5′‐triiodothyronine (rT3) into rat hepatocytes in primary culture due to a decrease of cellular ATP content and various drugs , 1982, FEBS letters.
[80] P. Larsen,et al. An analysis of the sources and quantity of 3,5,3'-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. , 1982, Endocrinology.
[81] S. Melmed,et al. A comparison of methods for assessing thyroid function in nonthyroidal illness. , 1982, The Journal of clinical endocrinology and metabolism.
[82] E. Kaptein,et al. Free thyroxine estimates in nonthyroidal illness: comparison of eight methods. , 1981, The Journal of clinical endocrinology and metabolism.
[83] P. Larsen,et al. Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. , 1981, Endocrine reviews.
[84] R. Utiger. Decreased extrathyroidal triiodothyronine production in nonthyroidal illness: benefit or harm? , 1980, The American journal of medicine.
[85] D. Solomon,et al. Misleadingly low free thyroxine index and usefulness of reverse triiodothyronine measurement in nonthyroidal illnesses. , 1979, Annals of internal medicine.
[86] H. Samuels,et al. Relationship of receptor affinity to the modulation of thyroid hormone nuclear receptor levels and growth hormone synthesis by L-triiodothyronine and iodothyronine analogues in cultured GH1 cells. , 1979, The Journal of clinical investigation.
[87] C. Stanley,et al. Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation. , 1979, The New England journal of medicine.
[88] D. Solomon,et al. Reciprocal changes in serum concentrations of 3,3',5-triiodothyronine (T3) in systemic illnesses. , 1975, The Journal of clinical endocrinology and metabolism.
[89] S. Refetoff,et al. Parameters of thyroid function in serum of 16 selected vertebrate species: a study of PBI, serum T4, free T4, and the pattern of T4 and T3 binding to serum proteins. , 1970, Endocrinology.
[90] G F Cahill,et al. Starvation in man. , 1970, The New England journal of medicine.
[91] J. H. Duke,et al. Tissue fuel and weight loss after injury. , 1970, Journal of clinical pathology. Supplement.
[92] J. Oppenheimer. Role of plasma proteins in the binding, distribution and metabolism of the thyroid hormones. , 1968, The New England journal of medicine.
[93] J. E. Rall,et al. Thyroxine-serum protein complexes in various animals. , 1962, Endocrinology.